As the first quarter of 2015 has finished we are able to provide you with relevant analysis reflecting the institutional investors’ equity portfolios returns based on the 13F...
Keep Reading →
April 8 - Hedge Funds, News
Billionaire Julian Robertson is a hedge fund legend and his opinion is highly valued on the Street, which is one of the reasons why we follow Tiger Management and analyze its ...
Keep Reading →
April 8 - Hedge Funds, News
The first quarter of 2015 is over and before hedge funds start releasing their Form 13F filings over the next 45 days, we will take a look at the performance of the stocks they...
Keep Reading →
April 2 - Hedge Funds, News
Ray Dalio's Bridgewater Associates, which is one of the world's largest hedge funds, revealed its equity portfolio in a filing with SEC.
Keep Reading →
March 17 - Hedge Funds, News
Billionaire Julian Robertson‘s hedge fund Tiger Management, disclosed an equity portfolio valued at some $509.8 million as of the end of 2014.
Keep Reading →
March 13 - Hedge Funds, News
Jeremy Green’s Redmile Group entered several new positions last quarter, as revealed by the 13F Form it filed with the U.S. Securities and Exchange Commission in February.
Keep Reading →
March 2 - Hedge Funds, News
Arthur B. Cohen and Joseph Healey’s Healthcor Management LP recently filed its latest 13F with the SEC, disclosing its equity positions at the end of 2014.
Keep Reading →
March 2 - Hedge Funds, News
The healthcare sector is one that has been performing very well in the short, but also medium and long-term.
Keep Reading →
February 24 - Hedge Funds, News
With the high volatility prevalent in the biotechnology sector, investors have a hard time picking the right stocks to invest in.
Keep Reading →
February 23 - Hedge Funds, News
With the business of analyzing and compiling the data of our 737 tracked hedge funds’ latest 13F filings behind us, we’re ready to start sharing some of the findings from ...
Keep Reading →
February 19 - Hedge Fund Analysis, Hedge Funds, News
Julian Robertson's Tiger Management has considerably increased the market value of its portfolio during the last quarter (nearly 35%).
Keep Reading →
February 18 - Hedge Funds, Tech
Ray Dalio’s Bridgewater Associates revealed its top picks for the fourth quarter in a 13F Form filed with the U.S. Securities and Exchange Commission.
Keep Reading →
February 17 - Hedge Funds, News
Express Scripts Holding Company (NASDAQ:ESRX) desire to accord Hepatitis C patients with what it believes to be the best of care has seen it ink a discounted deal with AbbVie...
Keep Reading →
December 22 - News
Gilead Sciences, Inc. (NASDAQ:GILD), AbbVie Inc (NYSE:ABBV) and Merck & Co., Inc. (NYSE:MRK) have participated at the liver meeting in Boston, Massachusetts.
Keep Reading →
November 10 - News
Saira Malik of TIAA-CREF stated on CNBC that is time to change their portfolio, so Gilead Sciences, Inc. (NASDAQ:GILD) is shorted and Honeywell International Inc.
Keep Reading →
September 12 - News
After being a dominant player in the hepatitis C market with its drug Sovaldi, Gilead Sciences, Inc.
Keep Reading →
July 18 - News
Bernard Selz’s Selz Capital recently disclosed at the SEC its long equity positions as of June 30 2014.
Keep Reading →
July 14 - Hedge Funds, News
Ghost Tree Capital is a healthcare-oriented hedge fund headquartered in New York.
Keep Reading →
February 27 - Hedge Funds, News
New York City-based Iguana Healthcare Management was founded by Stuart Weisbrod in 2010.
Keep Reading →
February 25 - Hedge Funds, News
Rock Springs Capital Management is a Baltimore-based hedge fund founded in February 2013 by Kris Jenner. Prior to that, Jenner had spent 14 years working at T.
Keep Reading →
February 24 - Hedge Funds, News
In the latest 13F filing, Julian Robertson's Tiger Management has disclosed its holdings as held at the end of the fourth quarter of 2013.
Keep Reading →
February 16 - Hedge Funds, News
It's really amazing to think about how far we've come over even the past decade in the health-care arena.
Keep Reading →
September 23 - News
There are few, if any, businesses in the world where innovation isn't the top priority.
Keep Reading →
September 14 - News
According to a recent Bloomberg report, Gilead Sciences, Inc.
Keep Reading →
September 11 - News
Sector exchange-traded funds, or ETFs, allow nervous investors to sample from the fast-paced health care industry with lessened risk.
Keep Reading →
September 10 - News
Peregrine Pharmaceuticals (NASDAQ:PPHM) will release its latest quarterly report on Monday, and investors are under no illusions that the company will avoid losing money again...
Keep Reading →
September 5 - News
ViiV Healthcare -- a joint venture by Pfizer Inc.
Keep Reading →
August 28 - News
One of the company's ushering in the next generation of hepatitis-C treatment is Gilead Sciences, Inc. (NASDAQ:GILD).
Keep Reading →
August 28 - News
"Bubble" can be a provocative word in investing circles. Think of all that comes to mind when you hear it -- perhaps other words like over-hyped, overvalued, risky, etc.
Keep Reading →
August 27 - News
We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors.
Keep Reading →
August 27 - Hedge Funds
To the average investor, there are tons of metrics shareholders can use to analyze stocks. Some of the most innovative are hedge fund and insider trading activity.
Keep Reading →
August 25 - News
The biotech industry is a marvel among traders and investors because it can double your investment, or halve it, based on a single clinical study.
Keep Reading →
August 25 - News
To many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Keep Reading →
August 23 - News
HIV, the virus that causes AIDS, has become one of the world's most devastating diseases since it was first recognized more than three decades ago.
Keep Reading →
August 23 - News
For a subgroup of the patients, the hazard ratio for overall survival in late-stage pancreatic cancer patients taking Incyte Corporation (NASDAQ:INCY)'s Jakafi and Roche's Xeloda...
Keep Reading →
August 23 - News
To many traders, hedge funds are perceived as overrated, outdated investment tools of a forgotten age.
Keep Reading →
August 22 - News
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Keep Reading →
August 22 - News
About 15,680 Americans are diagnosed with chronic lymphocytic leukemia, or CLL, and approximately 5,000 new cases of mantle cell lymphoma, or MCL, occur in the U.S.
Keep Reading →
August 21 - News
If you were to ask many investors, hedge funds are seen as delayed, old financial vehicles of an era lost to time.
Keep Reading →
August 21 - News
Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa for a moment, because these are exciting...
Keep Reading →
August 20 - News
If you've ever taken the time to really follow the biopharmaceutical sector, you know very well that failures are a dime a dozen, and success stories are few and far between.
Keep Reading →
August 19 - News
This could have been an enormously more difficult effort. I started out with the goal to identify the three best stocks in health care to buy and hold for years, even decades.
Keep Reading →
August 19 - News
At least the Food and Drug Administration is polite.
Keep Reading →
August 19 - News
Both ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) and Aegerion Pharmaceuticals, Inc.
Keep Reading →
August 5 - News
High yields aren't everything when you're searching for the perfect dividend stock.
Keep Reading →
August 1 - News
Cystic fibrosis (CF), a genetic disorder that affects the lungs, the pancreas, liver, and intestine, is the second most common inherited disorder in the United States, after sickle...
Keep Reading →
August 1 - News
We are in the midst of the earnings season, my favorite time of the year.
Keep Reading →
July 29 - News
Gilead Sciences, Inc. (NASDAQ:GILD)' shares surged over 5% in after-hours trading on Thursday after the company announced its second-quarter earnings before giving up some of...
Keep Reading →
July 29 - News
It's easy to forget that AbbVie Inc (NYSE:ABBV) is technically only seven-months old.
Keep Reading →
July 29 - News
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Keep Reading →
July 26 - News
